CYGB and melanoma: Meta-analysis of the whole-genome bead array dataset (GSE29359) comparing human primary melanocyte cell lines and 82 patient-derived metastatic melanoma samples demonstrated that although CYGB is mostly lost during melanocyte-to-melanoma transition, some melanoma cells retain their high endogenous CYGB levels [16].